Aerie Pharmaceuticals, Inc. - Common Stock (NQ:AERI)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 18, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aerie Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket ↗

August 23, 2022

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 23, 2022

Good morning! It's time for a breakdown of the biggest pre-market stock movers for Tuesday and the news that has them moving.

Via InvestorPlace

Palo Alto Networks, Aerie Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 23, 2022

Via Benzinga

Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio ↗

August 23, 2022

Via Benzinga

U.S. Stock Futures Edge Higher Following Monday's Sell-Off, Crude Oil Rises ↗

August 23, 2022

Pre-open movers

Via Benzinga

Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio

August 22, 2022

From Alcon Inc. Investors

Via Business Wire

Aerie Pharmaceuticals Announces New Employee Inducement Grant

August 15, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗

August 08, 2022

Gainers

Via Benzinga

Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session ↗

August 05, 2022

Gainers Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday.

Via Benzinga

Aerie Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

August 04, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 01, 2022

Via Benzinga

Aerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of AR-15512 for the Treatment of Dry Eye Disease

August 01, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on Thursday, August 4, 2022 at 5:00 p.m. ET

July 28, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals Announces New Employee Inducement Grant

July 08, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

Aerie Pharmaceuticals to Participate in the Jefferies Healthcare Conference on Friday, June 10, 2022 at 10:30 a.m. ET

May 25, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals Begins Patient Dosing In Late-Stage Dry Eye Disease Study ↗

May 24, 2022

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) has dosed the first patient in the Phase 3 COMET-2 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease...

Via Benzinga

Aerie Pharmaceuticals Announces First Participant Dosed in the Phase 3 Registrational COMET-2 Study of AR-15512 for the Treatment of Dry Eye Disease

May 24, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

HC Wainwright & Co. Maintains Buy Rating for Aerie Pharmaceuticals: Here's What You Need To Know ↗

May 09, 2022

HC Wainwright & Co. has decided to maintain its Buy rating of Aerie Pharmaceuticals (NASDAQ:AERI) and lower its price target from $25.00 to $20.00. Shares of Aerie Pharmaceuticals are trading down...

Via Benzinga

92 Biggest Movers From Friday ↗

May 09, 2022

Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...

Via Benzinga

Aerie Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

May 05, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Earnings Preview For Aerie Pharmaceuticals ↗

May 04, 2022

Aerie Pharmaceuticals (NASDAQ:AERI) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Aerie...

Via Benzinga

Aerie Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on Thursday, May 5, 2022 at 5:00 p.m. ET

April 28, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals Announces Presentations at the Association for Research in Vision and Ophthalmology Annual Meeting in Denver, Colorado, May 1-4, 2022

April 26, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Cannabis Movers & Shakers: SuperNet, MediPharm, Le-Vel, Jupiter Wellness, Leafly, Acreage ↗

April 22, 2022

SuperNet Names John Pfisterer As CFO SuperNet, a payment network that enables credit card payments for cannabis merchants and consumers, has tapped John Pfisterer to oversee its financial department.

Via Benzinga

Aerie Pharmaceuticals Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2022) in Washington, D.C., April 22-26, 2022

April 20, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 3:00 p.m. ET

April 06, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer

March 18, 2022

From Aerie Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.